Results 101 to 110 of about 24,656 (219)

Empleo del captopril en la determinación de la viabilidad miocárdica en una ventriculografía nuclear. Captopril usage in determining myocardial viability on a nuclear ventriculography.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 1997
Con el propósito de diagnosticar la viabilidad miocárdica en pacientes infartados con pobre función ventricular, empleamos el efecto vasodilatador del captopril en una ventriculografía nuclear.
Ana Ma. Maltas Pineda, Adlin López Díaz, Felizardo Ponce Vicente, David García Barreto, Amalia Peix González   +4 more
doaj  

Computational Insights into Captopril’s Inhibitory Potential Against MMP9 and LCN2 in Bladder Cancer: Implications for Therapeutic Application

Cancer Informatics
Objectives: Captopril is a commonly used therapeutic agent in the management of renovascular hypertension (high blood pressure), congestive heart failure, left ventricular dysfunction following myocardial infarction, and nephropathy.
Sanjida Kabir Annana, Jannatul Ferdoush, Farzia Lamia, Ayan Roy, Pallab Kar, Monisha Nandi, Maliha Kabir, Ayan Saha   +7 more
doaj   +1 more source

The prooxidant properties of captopril

, 1995
- The thiol drug captopril has been reported to possess reducing and transition metal-binding properties, which could result in specific changes in iron and copper prooxidant capacity.
Di Ilio C, de Gioia S, LAPENNA, Domenico, Ciofani G, Cuccurullo F., Mezzetti A   +5 more
core  

Trend 2 as depicted by Mylan Captopril.

, 2019
Trend 2 as depicted by Mylan Captopril.
Fatima Suleman (4118119), Rajatheran Moodley (7109351)   +1 more
core   +1 more source

Testing Antiviral Capabilities of Captopril in Mus musculus

, 2016
Existing treatments for Herpes Simplex Virus Type I (HSV-1) have negative effects including nephrotoxicity and increasing rates of drug resistance. The use of Captopril against the Herpes Simplex Virus-1 (HSV-1) provides a possible alternative to other ...
Rozema, Nicholas, Skinner, Kristina
core  

Hemodynamic and humoral interactions between captopril and nifedipine.

, 1983
Nine patients with uncomplicated essential hypertension received, according to a randomized sequence, captopril (25 mg three times daily), nifedipine (10 mg three times daily), and both drugs for 1 week, with each treatment period separated by a 1-week ...
Pisani R, Di Rao G, PEDRINELLI, ROBERTO, Stornello M, Scapellato L, Salvetti A., Iachello M   +6 more
core  

Captopril usage in determining myocardial viability on a nuclear ventriculography

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2014
In order to diagnose myocardial viability in infarct patients with depressed ventricular function, we used the vasodilator effect of Captopril in a nuclear ventriculography.
Amalia Peix González, David García Barreto, Felizardo Ponce Vicente, Adlin López Díaz, Ana Ma. Maltas Pineda   +4 more
doaj  

Cutaneous reactions to captopril: Predictive value of skin tests

, 1984
Cutaneous reactions associated with captopril treatment occurred in fifteen out of eighty-nine patients (17%). Dose reduction invariably led to improvement of the reaction but later recurrences were frequent (six patients).
van der Laan, S, de Monchy, J, Donker, AJM, Smit, AJ, Kallenberg, CGM   +4 more
core  

Detection of renal artery stenosis: prospective comparison of captopril-enhanced Doppler sonography, captopril-enhanced scintigraphy, and MR angiography.

, 2001
OBJECTIVE: The objective of our study was to compare the value of captopril-enhanced Doppler sonography, captopril-enhanced renal scintigraphy, and gadolinium-enhanced MR angiography for detecting renal artery stenosis.
Oliva, V.L., Qanadli, S.D., Guertin, M.C., Froment, D., Therasse, E., Soulez, G., Nicolet, V., Courteau, M., Turpin, S.   +8 more
core  

Kinetics of cardiac and vascular remodeling by spontaneously hypertensive rats after discontinuation of long-term captopril treatment

Brazilian Journal of Medical and Biological Research, 2010
Angiotensin-converting enzyme inhibitors reduce blood pressure and attenuate cardiac and vascular remodeling in hypertension. However, the kinetics of remodeling after discontinuation of the long-term use of these drugs are unknown.
W.A. Rocha, W. Lunz, M.P. Baldo, E.B. Pimentel, E.M. Dantas, S.L. Rodrigues, J.G. Mill   +6 more
doaj